Home › Funds › Aufman Associates Inc › MRNA

Aufman Associates Inc position in MRNA

MODERNA INC · Health Care

Aufman Associates Inc reported holding 65,687 shares of MRNA (MODERNA INC) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 1.82% of its reported portfolio and ranking #8 among its reported holdings. Aufman Associates Inc has disclosed MRNA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)65.69K sh
Reported value held$4.58M
Portfolio Weight1.82%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Aufman Associates Inc's MRNA position evolved

Aufman Associates Inc first disclosed a stake in MRNA in Q1 2024 at 4,300 shares (US$458K). The position peaked in Q2 2026 at 65,687 shares, worth US$4.6M. Across 10 filings, Aufman Associates Inc increased the stake 9 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 65,687 shares valued at US$4.6M — an increase of 8,689 shares quarter over quarter.. Notable position changes include a 51% increase in Q2 2024 (shares fell 44% over the following quarter), a 35% increase in Q3 2024 (shares fell 38% over the following quarter), a 147% increase in Q4 2025 (shares rose 72% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 4.30K $458.21K New
Q2 2024 6.51K $772.59K Add
Q3 2024 8.77K $585.90K Add
Q4 2024 11.07K $460.12K Add
Q1 2025 14.87K $462.88K Add
Q2 2025 16.19K $439.75K Add
Q3 2025 17.51K $452.26K Add
Q4 2025 43.20K $1.27M Add
Q1 2026 57.00K $2.75M Add
Q2 2026 65.69K $4.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Aufman Associates Inc held MRNA?

Aufman Associates Inc has disclosed MRNA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Aufman Associates Inc's current position in MRNA?

As of Q2 2026, Aufman Associates Inc holds 65.69K shares of MRNA (MODERNA INC), valued at $4.58M, representing 1.82% of its reported portfolio and ranking #8.

Has Aufman Associates Inc been buying or selling MRNA?

In the latest 13F filing (Q2 2026), Aufman Associates Inc increased its position in MRNA. The position peaked in Q2 2026 at 65.69K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.